Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound omeprazole capsule in active duodenal ulcer
CTR20160165Phase 3Active
- Sponsor
- Beijing Huicheng Ruixiang Pharmaceutical Biotechnology
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omeprazole in duodenal ulcer, sponsored by Beijing Huicheng Ruixiang Pharmaceutical Biotechnology. Started Apr 2016; status: active.
02
Drugs
omeprazole
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on CTR20160165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160165.